{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:16:52Z","timestamp":1785251812257,"version":"3.55.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007917","name":"Agricultural Research Service","doi-asserted-by":"publisher","award":["6040-32000-081-00D"],"award-info":[{"award-number":["6040-32000-081-00D"]}],"id":[{"id":"10.13039\/100007917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009168","name":"Animal and Plant Health Inspection Service","doi-asserted-by":"publisher","award":["60-6040-2-008"],"award-info":[{"award-number":["60-6040-2-008"]}],"id":[{"id":"10.13039\/100009168","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-SC0014664"],"award-info":[{"award-number":["DE-SC0014664"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The outbreak of clade 2.3.4.4b H5 highly pathogenic avian influenza (HPAI) in North America that started in 2021 has increased interest in applying vaccination as a strategy to help control and prevent the disease in poultry. Two commercially available vaccines based on the recombinant herpes virus of turkeys (rHVT) vector were tested against a recent North American clade 2.3.4.4b H5 HPAI virus isolate: A\/turkey\/Indiana\/22-003707-003\/2022 H5N1 in specific pathogen free white leghorn (WL) chickens and commercial broiler chickens. One rHVT-H5 vaccine encodes a hemagglutinin (HA) gene designed by the computationally optimized broadly reactive antigen method (COBRA-HVT vaccine). The other encodes an HA gene of a clade 2.2 virus (2.2-HVT vaccine). There was 100% survival of both chicken types COBRA-HVT vaccinated groups and in the 2.2-HVT vaccinated groups there was 94.8% and 90% survival of the WL and broilers respectively. Compared to the 2.2-HVT vaccinated groups, WL in the COBRA-HVT vaccinated group shed significantly lower mean viral titers by the cloacal route and broilers shed significantly lower titers by the oropharyngeal route than broilers. Virus titers detected in oral and cloacal swabs were otherwise similar among both vaccine groups and chicken types. To assess antibody-based tests to identify birds that have been infected after vaccination (DIVA-VI), sera collected after the challenge were tested with enzyme-linked lectin assay-neuraminidase inhibition (ELLA-NI) for N1 neuraminidase antibody detection and by commercial ELISA for detection of antibodies to the NP protein. As early as 7 days post challenge (DPC) 100% of the chickens were positive by ELLA-NI. ELISA was less sensitive with a maximum of 75% positive at 10DPC in broilers vaccinated with 2.2-HVT. Both vaccines provided protection from challenge to both types of chickens and ELLA-NI was sensitive at identifying antibodies to the challenge virus therefore should be evaluated further for DIVA-VI.<\/jats:p>","DOI":"10.1371\/journal.pone.0307100","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T17:31:21Z","timestamp":1721151081000},"page":"e0307100","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-6576","authenticated-orcid":true,"given":"Jiho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5699-998X","authenticated-orcid":true,"given":"Taejoong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-2360","authenticated-orcid":true,"given":"Erica","family":"Spackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"issue":"3","key":"pone.0307100.ref001","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/irv.12230","article-title":"Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses.","volume":"8","author":"World Health Organization\/World Organisation for Animal HF, Agriculture Organization HNEWG","year":"2014","journal-title":"Influenza Other Respir Viruses."},{"issue":"2","key":"pone.0307100.ref002","article-title":"Pathobiological Origins and Evolutionary History of Highly Pathogenic Avian Influenza Viruses.","volume":"11","author":"DH Lee","year":"2021","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"6","key":"pone.0307100.ref003","article-title":"The Emergence and Decennary Distribution of Clade 2.3.4.4 HPAI H5Nx.","volume":"7","author":"KJC Antigua","year":"2019","journal-title":"Microorganisms"},{"issue":"5","key":"pone.0307100.ref004","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3201\/eid2805.220318","article-title":"Intercontinental Movement of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4 Virus to the United States, 2021.","volume":"28","author":"SN Bevins","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"pone.0307100.ref005","first-page":"57923","author":"Service AaPHI","year":"2023","journal-title":"Notice of Availability of a Draft Supplemental Environmental Assessment and Draft Finding of No Significant Impact for Emergency Response for Highly Pathogenic Avian Influenza Outbreaks in the United States Migratory Bird Flyways In: USDA-APHIS, editor."},{"key":"pone.0307100.ref006","first-page":"37","volume-title":"Maisons-Alfort: Anses","author":"Anses","year":"2023"},{"issue":"3","key":"pone.0307100.ref007","first-page":"839","article-title":"Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination.","volume":"30","author":"DE Swayne","year":"2011","journal-title":"Revue scientifique et technique."},{"issue":"3","key":"pone.0307100.ref008","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1637\/0005-2086-65.3.438","article-title":"Review of Poultry Recombinant Vector Vaccines","volume":"65","author":"R Hein","year":"2021","journal-title":"Avian Dis"},{"issue":"9","key":"pone.0307100.ref009","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.vaccine.2014.12.028","article-title":"Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus","volume":"33","author":"DR Kapczynski","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"pone.0307100.ref010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.tvjl.2014.09.017","article-title":"Practical aspects of vaccination of poultry against avian influenza virus.","volume":"202","author":"E Spackman","year":"2014","journal-title":"Vet J"},{"issue":"1","key":"pone.0307100.ref011","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virusres.2013.03.004","article-title":"Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: current questions and new technology","volume":"178","author":"E Spackman","year":"2013","journal-title":"Virus Res"},{"key":"pone.0307100.ref012","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.vetmic.2016.11.024","article-title":"Marek\u2019s disease vaccines: Current status, and strategies for improvement and development of vector vaccines","volume":"206","author":"SM Reddy","year":"2017","journal-title":"Vet Microbiol"},{"issue":"1","key":"pone.0307100.ref013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1637\/11282-091615-Reg.1","article-title":"Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).","volume":"60","author":"MJ Pantin-Jackwood","year":"2016","journal-title":"Avian Dis"},{"issue":"43","key":"pone.0307100.ref014","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1016\/j.vaccine.2018.09.015","article-title":"Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens","volume":"36","author":"K Bertran","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"pone.0307100.ref015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/03079457.2020.1790502","article-title":"Herpesvirus of turkey-vectored avian influenza vaccine offers cross-protection against antigenically drifted H5Nx highly pathogenic avian influenza virus strains","volume":"49","author":"S Nassif","year":"2020","journal-title":"Avian Pathol"},{"issue":"7","key":"pone.0307100.ref016","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2021.01.018","article-title":"A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity","volume":"39","author":"S Reemers","year":"2021","journal-title":"Vaccine"},{"issue":"18","key":"pone.0307100.ref017","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.vaccine.2023.03.055","article-title":"Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses","volume":"41","author":"MF Criado","year":"2023","journal-title":"Vaccine"},{"issue":"21","key":"pone.0307100.ref018","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.vaccine.2021.04.022","article-title":"Efficacy of two vaccines against recent emergent antigenic variants of clade 2.3.2.1a highly pathogenic avian influenza viruses in Bangladesh","volume":"39","author":"JH Kwon","year":"2021","journal-title":"Vaccine"},{"issue":"46","key":"pone.0307100.ref019","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1016\/j.vaccine.2017.05.051","article-title":"Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus","volume":"35","author":"K Bertran","year":"2017","journal-title":"Vaccine"},{"key":"pone.0307100.ref020","doi-asserted-by":"crossref","first-page":"3143189","DOI":"10.1155\/2018\/3143189","article-title":"Efficacy of a Recombinant Turkey Herpesvirus AI (H5) Vaccine in Preventing Transmission of Heterologous Highly Pathogenic H5N8 Clade 2.3.4.4b Challenge Virus in Commercial Broilers and Layer Pullets.","volume":"2018","author":"V Palya","year":"2018","journal-title":"J Immunol Res"},{"issue":"6","key":"pone.0307100.ref021","doi-asserted-by":"crossref","first-page":"e0156747","DOI":"10.1371\/journal.pone.0156747","article-title":"Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.","volume":"11","author":"WH Kilany","year":"2016","journal-title":"PLoS One."},{"issue":"1 Suppl","key":"pone.0307100.ref022","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1637\/11129-050715-Reg","article-title":"Recombinant Turkey Herpesvirus-AI Vaccine Virus Replication in Different Species of Waterfowl","volume":"60","author":"V Palya","year":"2016","journal-title":"Avian Dis"},{"issue":"4 Suppl","key":"pone.0307100.ref023","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1637\/10207-041512-Review.1","article-title":"DIVA vaccination strategies for avian influenza virus","volume":"56","author":"DL Suarez","year":"2012","journal-title":"Avian Dis"},{"key":"pone.0307100.ref024","doi-asserted-by":"crossref","first-page":"909297","DOI":"10.3389\/fimmu.2022.909297","article-title":"Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.","volume":"13","author":"MC Bernard","year":"2022","journal-title":"Front Immunol"},{"key":"pone.0307100.ref025","article-title":"Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens","author":"E Spackman","year":"2023","journal-title":"Vaccine"},{"issue":"3","key":"pone.0307100.ref026","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/21645515.2015.1012013","article-title":"Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.","volume":"11","author":"CJ Crevar","year":"2015","journal-title":"Hum Vaccin Immunother."},{"issue":"16","key":"pone.0307100.ref027","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets.","volume":"29","author":"BM Giles","year":"2011","journal-title":"Vaccine"},{"key":"pone.0307100.ref028","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-0716-0346-8_12","article-title":"Avian Influenza Virus Isolation, Propagation, and Titration in Embryonated Chicken Eggs.","volume":"2123","author":"E Spackman","year":"2020","journal-title":"Methods Mol Biol"},{"key":"pone.0307100.ref029","first-page":"493","article-title":"A simple method for estimating fifty percent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"American Journal of Hygiene"},{"key":"pone.0307100.ref030","first-page":"2021","article-title":"Recombinant HVT vectors expressing influenza hamagglutinin and immunogenic compositions and production and use thereof.","volume":"23","author":"inventors","journal-title":"USA patent W0 2021\/257706 A1."},{"issue":"6","key":"pone.0307100.ref031","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/104063870902100603","article-title":"Removal of real-time reverse transcription polymerase chain reaction (RT-PCR) inhibitors associated with cloacal swab samples and tissues for improved diagnosis of Avian influenza virus by RT-PCR.","volume":"21","author":"A Das","year":"2009","journal-title":"Journal of Veterinary Diagnostic Investigation"},{"issue":"9","key":"pone.0307100.ref032","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1128\/JCM.40.9.3256-3260.2002","article-title":"Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes","volume":"40","author":"E Spackman","year":"2002","journal-title":"Journal of Clinical Microbiology"},{"key":"pone.0307100.ref033","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-0716-0346-8_2","article-title":"Hemagglutination Inhibition Assay.","volume":"2123","author":"E Spackman","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"286","key":"pone.0307100.ref034","first-page":"491","article-title":"Simplified Estimators for the Normal-Distribution When Samples Are Singly Censored or Truncated","volume":"54","author":"AC Cohen","year":"1959","journal-title":"J Am Stat Assoc"},{"issue":"38","key":"pone.0307100.ref035","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1016\/j.vaccine.2023.07.076","article-title":"Prediction of highly pathogenic avian influenza vaccine efficacy in chickens by comparison of in vitro and in vivo data: A meta-analysis and systematic review","volume":"41","author":"J Mo","year":"2023","journal-title":"Vaccine"},{"key":"pone.0307100.ref036","article-title":"OIE Terrestrial Manual.","author":"World Health Organization\/World Organisation for Animal HF","year":"2021","journal-title":"In: Manual"},{"key":"pone.0307100.ref037","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.rvsc.2021.08.012","article-title":"Examination of the protective efficacy of two avian influenza H5 vaccines against clade 2.3.4.4b H5N8 highly pathogenic avian influenza virus in commercial broilers","volume":"140","author":"NA El-Shall","year":"2021","journal-title":"Res Vet Sci"},{"issue":"1","key":"pone.0307100.ref038","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/03079458708436352","article-title":"Enhancement of natural killer cell activity by Marek\u2019s disease vaccines","volume":"16","author":"ED Heller","year":"1987","journal-title":"Avian Pathology"},{"issue":"3","key":"pone.0307100.ref039","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.vaccine.2009.10.049","article-title":"Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old","volume":"28","author":"F Rauw","year":"2010","journal-title":"Vaccine"},{"issue":"1\u20132","key":"pone.0307100.ref040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vetimm.2013.11.008","article-title":"Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers","volume":"158","author":"V Palya","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"key":"pone.0307100.ref041","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.vetimm.2017.08.001","article-title":"Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus","volume":"191","author":"DR Kapczynski","year":"2017","journal-title":"Vet Immunol Immunopathol"},{"key":"pone.0307100.ref042","doi-asserted-by":"crossref","DOI":"10.18174\/584306","author":"VF Germeraad EA","year":"2023","journal-title":"Transmissiestudie met vier vaccins tegen H5N1 hoogpathogeen vogelgriepvirus (clade 2.3.4.4b) Available online: https:\/\/edepot.wur.nl\/584306: Wageningen Bioveterinary Research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T17:31:51Z","timestamp":1721151111000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307100"}},"subtitle":[],"editor":[{"given":"Vishwanatha R. A. P.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0307100","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]}}}